We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233 → 239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17% → 106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M

Top Buyers

1
DPCM
Doma Perpetual Capital Management
Florida
+$22M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.1M
3
American Century Companies
American Century Companies
Missouri
+$4.81M
4
Morgan Stanley
Morgan Stanley
New York
+$4.73M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.16M

Top Sellers

1
PCH
Polar Capital Holdings
United Kingdom
-$21.8M
2
BlackRock
BlackRock
New York
-$11.3M
3
EC
EcoR1 Capital
California
-$10.9M
4
Millennium Management
Millennium Management
New York
-$10.9M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
GRP
201
Global Retirement Partners
California
$9.02K – – –
TWD
202
True Wealth Design
Ohio
$8.79K – – –
AF
203
Allworth Financial
California
$8.38K -$737 -30 -8%
UB
204
UMB Bank
Missouri
$8.32K -$2.9K -118 -27%
SL
205
Salomon & Ludwin
Virginia
$8.3K +$8.2K +334 New
CA
206
Clearstead Advisors
Ohio
$7.6K – – –
MPWT
207
MassMutual Private Wealth & Trust
Connecticut
$7.29K -$2.9K -118 -29%
ASN
208
Advisory Services Network
Georgia
$5.98K +$5.7K +232 New
Optiver Holding
209
Optiver Holding
Netherlands
$5.62K +$5.35K +218 New
HCA
210
Harbor Capital Advisors
Illinois
$5K +$4.5K +183 New
Mitsubishi UFJ Asset Management
211
Mitsubishi UFJ Asset Management
Japan
$4.43K – – –
Daiwa Securities Group
212
Daiwa Securities Group
Japan
$4K – – –
PWA
213
Provenance Wealth Advisors
Florida
$3.87K – – –
PA
214
Parallel Advisors
California
$3.84K – – –
CSC
215
Caldwell Sutter Capital
California
$3.84K +$3.66K +149 New
S
216
SignatureFD
Georgia
$3.79K +$147 +6 +4%
CA
217
CoreCap Advisors
Michigan
$3.71K +$3.54K +144 New
EP
218
Essential Partners
California
$3.45K – – –
CT
219
Colonial Trust
South Carolina
$2.99K +$614 +25 +27%
RIL
220
Rothschild Investment LLC
Illinois
$2.71K +$123 +5 +5%
HI
221
Harbour Investments
Wisconsin
$2.58K – – –
NA
222
NewEdge Advisors
Louisiana
$2.58K – – –
VFM
223
Vision Financial Markets
Connecticut
$2.58K – – –
1NWS
224
1 North Wealth Services
Maryland
$2.19K – – –
WA
225
WPG Advisers
Maryland
$2.14K – – –
7 8
9
10 11

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.